BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 9317130)

  • 21. Cutting edge: TCR alpha beta+ CD8 alpha alpha+ T cells are found in intestinal intraepithelial lymphocytes of mice that lack classical MHC class I molecules.
    Gapin L; Cheroutre H; Kronenberg M
    J Immunol; 1999 Oct; 163(8):4100-4. PubMed ID: 10510343
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Thymocyte antigens do not induce tolerance in the CD4+ T cell compartment.
    Jhaver KG; Chandler P; Simpson E; Mellor AL
    J Immunol; 1999 Nov; 163(9):4851-8. PubMed ID: 10528186
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Can bone marrow-derived thymic stromal cells mediate the positive selection of class I-restricted T cells?
    Fort MM; Pardoll DM
    Cell Immunol; 1996 Jul; 171(1):74-9. PubMed ID: 8660840
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Virus infection expands a biased subset of T cells that bind tetrameric class I peptide complexes.
    Coles RM; Jones CM; Brooks AG; Cameron PU; Heath WR; Carbone FR
    Eur J Immunol; 2003 Jun; 33(6):1557-67. PubMed ID: 12778473
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Alterations in TCR-MHC contacts subsequent to cross-recognition of class I MHC and singly substituted peptide variants.
    Ono T; DiLorenzo TP; Wang F; Kalergis AM; Nathenson SG
    J Immunol; 1998 Nov; 161(10):5454-63. PubMed ID: 9820521
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Human CD4 residue Phe 43 is critical for repertoire development and maturation of MHC class II restricted CD4 single-positive T lineage cells in vivo.
    Sakihama T; Hunsicker ME; Hussey RE; Reinherz EL
    Eur J Immunol; 2000 Jan; 30(1):279-90. PubMed ID: 10602051
    [TBL] [Abstract][Full Text] [Related]  

  • 27. CD8 enhances formation of stable T-cell receptor/MHC class I molecule complexes.
    Garcia KC; Scott CA; Brunmark A; Carbone FR; Peterson PA; Wilson IA; Teyton L
    Nature; 1996 Dec; 384(6609):577-81. PubMed ID: 8955273
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A model for the origin of TCR-alphabeta+ CD4-CD8- B220+ cells based on high affinity TCR signals.
    Mixter PF; Russell JQ; Morrissette GJ; Charland C; Aleman-Hoey D; Budd RC
    J Immunol; 1999 May; 162(10):5747-56. PubMed ID: 10229807
    [TBL] [Abstract][Full Text] [Related]  

  • 29. TcR recognition of the MHC-peptide dimer: structural properties of a ternary complex.
    Vasmatzis G; Cornette J; Sezerman U; DeLisi C
    J Mol Biol; 1996 Aug; 261(1):72-89. PubMed ID: 8760503
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Phenotypes and invariant alpha beta TCR expression of peripheral V alpha 14+ NK T cells.
    Masuda K; Makino Y; Cui J; Ito T; Tokuhisa T; Takahama Y; Koseki H; Tsuchida K; Koike T; Moriya H; Amano M; Taniguchi M
    J Immunol; 1997 Mar; 158(5):2076-82. PubMed ID: 9036951
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A T cell receptor V alpha region selectively expressed in CD4+ cells.
    Jameson SC; Kaye J; Gascoigne NR
    J Immunol; 1990 Sep; 145(5):1324-31. PubMed ID: 1696594
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A novel role for HEB downstream or parallel to the pre-TCR signaling pathway during alpha beta thymopoiesis.
    Barndt R; Dai MF; Zhuang Y
    J Immunol; 1999 Sep; 163(6):3331-43. PubMed ID: 10477603
    [TBL] [Abstract][Full Text] [Related]  

  • 33. RAG-dependent peripheral T cell receptor diversification in CD8+ T lymphocytes.
    Serra P; Amrani A; Han B; Yamanouchi J; Thiessen SJ; Santamaria P
    Proc Natl Acad Sci U S A; 2002 Nov; 99(24):15566-71. PubMed ID: 12432095
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Autoantigen-independent deletion of diabetogenic CD4+ thymocytes by protective MHC class II molecules.
    Schmidt D; Amrani A; Verdaguer J; Bou S; Santamaria P
    J Immunol; 1999 Apr; 162(8):4627-36. PubMed ID: 10202002
    [TBL] [Abstract][Full Text] [Related]  

  • 35. TCR transgenic mice in which usage of transgenic alpha- and beta-chains is highly dependent on the level of selecting ligand.
    Kersh GJ; Donermeyer DL; Frederick KE; White JM; Hsu BL; Allen PM
    J Immunol; 1998 Jul; 161(2):585-93. PubMed ID: 9670931
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The expression of CD4 and CD8 molecules conditions the behavior of V beta + murine thymocytes upon superantigenic challenge.
    Fattorossi A; Baschieri S; Ferlini C; Doria G
    Thymus; 1997; 24(3):133-45. PubMed ID: 9151379
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The mode of ligand recognition by two peptide:MHC class I-specific monoclonal antibodies.
    Messaoudi I; LeMaoult J; Nikolić-Zugić J
    J Immunol; 1999 Sep; 163(6):3286-94. PubMed ID: 10477598
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Selective absence of CD8+ TCRalpha beta+ intestinal epithelial cells in transgenic mice expressing beta2-microglobulin-associated ligands exclusively on thymic cortical epithelium.
    Capone M; Lees RK; Finke D; Ernst B; Meerwijk JP; MacDonald HR
    Eur J Immunol; 2003 Jun; 33(6):1471-7. PubMed ID: 12778464
    [TBL] [Abstract][Full Text] [Related]  

  • 39. MHC and T cell development.
    Viret C; Janeway CA
    Rev Immunogenet; 1999; 1(1):91-104. PubMed ID: 11256575
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Limiting TCR expression leads to quantitative but not qualitative changes in thymic selection.
    Dave VP; Allman D; Wiest DL; Kappes DJ
    J Immunol; 1999 May; 162(10):5764-74. PubMed ID: 10229809
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.